CAS: 666842-36-0 - 3-[[3-[4-[[3-(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]propanamide
Formula:C26H40N4O8
InChI:InChI=1S/C26H40N4O8/c1-14(2)21-18(25(30-29-21)38-26-24(35)23(34)22(33)19(13-31)37-26)12-16-5-6-17(11-15(16)3)36-10-4-8-28-9-7-20(27)32/h5-6,11,14,19,22-24,26,28,31,33-35H,4,7-10,12-13H2,1-3H3,(H2,27,32)(H,29,30)/t19-,22-,23+,24-,26+/m1/s1
InChI key:InChIKey=MDBARDSTXONTFS-MNDUUMEHSA-N
SMILES:O=C(N)CCNCCCOC1=CC=C(C(=C1)C)CC=2C(=NNC2C(C)C)OC3OC(CO)C(O)C(O)C3O
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | KGA-2727 REF: TM-T15656CAS: 666842-36-0 | 98.95% | 131,00 €~1.388,00 € | Mer 04 Dic 24 |
 | KGA-2727 REF: 3D-RBB84236CAS: 666842-36-0 | Min. 95% | Prezzo su richiesta | Mer 15 Gen 25 |
KGA-2727
CAS:666842-36-0
KGA-2727: potent, selective SGLT1 inhibitor (human Ki 97.4 nM, rat 43.5 nM), with high selectivity …
Formula:
C26H40N4O8
Purezza:
98.95%
Colore e forma:
Solid
Peso molecolare:
536.62
Ref: TM-T15656
| 1mg | 131,00 € | ||
| 2mg | 180,00 € | ||
| 5mg | 271,00 € | ||
| 10mg | 449,00 € | ||
| 25mg | 740,00 € | ||
| 50mg | 1.013,00 € | ||
| 100mg | 1.388,00 € | ||
| 1mL*10mM (DMSO) | 318,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 04 Dicembre 2024
KGA-2727
CAS:666842-36-0
KGA-2727 is a novel, orally administered, non-peptidic, small molecule antidiabetic agent that increases glucose uptake …
Formula:
C26H40N4O8
Purezza:
Min. 95%
Peso molecolare:
536.6 g/mol
Ref: 3D-RBB84236
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Mercoledì 15 Gennaio 2025
